Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e50b4db47979637aa7b36f3fd7e5466 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ccf476419c0300b35a642c06da452fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c801647640bf2c309d31f673a74ea8d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_599bea0a306ee7d191528f7bc9390b99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ed366f99a1532833aa316cb7e80307 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eecea43b3f1c44c84ae357da3fbdb40 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-29 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-21 |
filingDate |
2012-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2bf3f6917ffdff378e62df36ba81f6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5ab1e7bc1a4575c660fdf4f7d3578a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab5e285856cef1f5a7bb40961a52d74e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e9036d34868d9a05da84ae2087b7cfd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b7f634be4c052c0936940c4ddada74f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d17f62f545ee6ff0c8326a7c30f61a |
publicationDate |
2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012220635-A1 |
titleOfInvention |
Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
abstract |
The present invention relates to aromatic compounds of the formula (I) and the physiologically tolerated acid addition salts thereof. The invention also relates to the use of a compound of the formula (I) or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D 3 receptor ligand. |
priorityDate |
2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |